Sekisui Diagnostics OSOM Ultra Plus Flu A & B Test

Sekisui Diagnostics

Sekisui Diagnostics OSOM Ultra Plus Flu A & B Test

SKU: 559992
MFG Part #: 1032
  • Providing superior rapid results at the point-of-care. Fast, easy, cost effective so you can test and treat in one visit.
  • Meets the Influenza reclassification requirements for rapid antigen tests
  • Simple CLIA-waived procedure with pre-measured extraction buffer for swab samples
  • Accurate, differentiated interpretation of results in 10 minutes to test and treat patients in one office visit
  • Made In USA
    True Know-How
    Ask our experts
    In Stock
    Free Shipping
    Usually ships in 1 - 3 Days
    This product is non-returnable

    Price:
    $309.94 25 Test Per / Kit
    GPO Price:
    $200.00

    Description

    The OSOM Ultra Plus Flu A & B Test is an in vitro rapid qualitative test that detects influenza type A and type B nucleoprotein antigens directly from nasal swab and nasopharyngeal swab specimens obtained from patients with signs and symptoms of respiratory infection.

    Features

    • Simple CLIA-waived procedure with pre-measured extraction buffer for swab samples
    • Accurate, differentiated interpretation of results in 10 minutes to test and treat patients in one office visit
    • Meets the Influenza reclassification requirements for rapid antigen tests

    Product Specifications and Resources

    Number of Tests 25 Tests (plus 2 extra for external QC)
    Reading Type Visual Read
    Sample Type Nasal Swab / Nasopharyngeal Swab Sample
    Test Format Dipstick Format
    Test Name Influenza A + B
    Test Type Infectious Disease Immunoassay
    Time to Results 10 Minute Results
    Kit Storage Fahrenheit 59°-86°
    Kit Storage Celsius 15°-30°
    Shelf Life 18 months from manufacture
    What's in the Box
  • (25) Test Sticks
  • (25) Sterile Nasal Swabs
  • (25) Extraction Buffer Vials
  • (1) Influenza A+ Control Swab
  • (1) Influenza B+ Control Swab
    Documents & Resources

    Customers Also Bought

    Recently viewed